CAC
NBRV

Certified Advisory Corp’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Certified Advisory Corp’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$4K – 805
2021
Q1 		$4K Buy
+100
New +$6.21K ﹤0.01% 704

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Certified Advisory Corp's NBRV Position: Q2 2021 in Review

Certified Advisory Corp sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2021, closing a stake of 100 shares — an estimated $4K sold.

Certified Advisory Corp first reported a position in NBRV in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 31 funds tracked by Wall St. Rank hold NBRV as of Q2 2021.

  • Certified Advisory Corp reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2021 after selling out during the quarter.
  • Certified Advisory Corp sold 100 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2021, an estimated $4K.
  • Certified Advisory Corp first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q1 2021 and held it in 1 quarter.
  • Certified Advisory Corp's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $4K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.